SUMMARY China Automotive Systems (NASDAQ:CAAS) reported a 19.9% top-line increase in the first quarter of 2025 and ...
Big pharma is increasingly shopping in China to fill its pipelines as it faces looming patent cliffs on major blockbusters coupled with growing pricing pressures on drugs. As previously reported by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results